These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23800540)

  • 1. Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.
    Coleman JK; Pu R; Martin MM; Noon-Song EN; Zwijnenberg R; Yamamoto JK
    Vaccine; 2014 Feb; 32(6):746-54. PubMed ID: 23800540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection.
    Aranyos AM; Roff SR; Pu R; Owen JL; Coleman JK; Yamamoto JK
    Vaccine; 2016 Mar; 34(12):1480-8. PubMed ID: 26802606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.
    Pu R; Coleman J; Coisman J; Sato E; Tanabe T; Arai M; Yamamoto JK
    J Feline Med Surg; 2005 Feb; 7(1):65-70. PubMed ID: 15686976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine.
    Sahay B; Yamamoto JK
    Viruses; 2018 May; 10(5):. PubMed ID: 29789450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
    Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
    AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
    Yamamoto JK; Sanou MP; Abbott JR; Coleman JK
    Curr HIV Res; 2010 Jan; 8(1):14-25. PubMed ID: 20210778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
    Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine.
    Bęczkowski PM; Harris M; Techakriengkrai N; Beatty JA; Willett BJ; Hosie MJ
    Vaccine; 2015 Feb; 33(8):977-84. PubMed ID: 25613718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of protection against feline immunodeficiency virus infection among domestic cats in New Zealand vaccinated with the Fel-O-Vax® FIV vaccine.
    Stickney A; Ghosh S; Cave NJ; Dunowska M
    Vet Microbiol; 2020 Nov; 250():108865. PubMed ID: 33045631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of Feline ELISpot to Evaluate the Immunogenicity of a T Cell-Based FIV MAP Vaccine.
    Sahay B; Aranyos AM; McAvoy A; Yamamoto JK
    Methods Mol Biol; 2018; 1808():197-219. PubMed ID: 29956186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax
    Westman M; Yang D; Green J; Norris J; Malik R; Parr YA; McDonald M; Hosie MJ; VandeWoude S; Miller C
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33809232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates.
    Pu R; Coleman J; Omori M; Arai M; Hohdatsu T; Huang C; Tanabe T; Yamamoto JK
    AIDS; 2001 Jul; 15(10):1225-37. PubMed ID: 11426067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism(s) of FIV vaccine protection.
    Pu R; Tellier MC; Yamamoto JK
    Leukemia; 1997 Apr; 11 Suppl 3():98-101. PubMed ID: 9209311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
    Hofmann-Lehmann R; Holznagel E; Aubert A; Ossent P; Reinacher M; Lutz H
    Vet Immunol Immunopathol; 1995 May; 46(1-2):127-37. PubMed ID: 7618252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental vaccine protection against feline immunodeficiency virus.
    Yamamoto JK; Okuda T; Ackley CD; Louie H; Pembroke E; Zochlinski H; Munn RJ; Gardner MB
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):911-22. PubMed ID: 1662057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
    Lehmann R; von Beust B; Niederer E; Condrau MA; Fierz W; Aubert A; Ackley CD; Cooper MD; Tompkins MB; Lutz H
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):199-214. PubMed ID: 1363009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines.
    Hosie MJ; Osborne R; Yamamoto JK; Neil JC; Jarrett O
    J Virol; 1995 Feb; 69(2):1253-5. PubMed ID: 7815500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses.
    Sahay B; Aranyos AM; Mishra M; McAvoy AC; Martin MM; Pu R; Shiomitsu S; Shiomitsu K; Dark MJ; Sanou MP; Roff SR; Rathore MH; Yamamoto JK
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30717485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dual-subtype vaccine against feline immunodeficiency virus infection.
    Hohdatsu T; Okada S; Motokawa K; Aizawa C; Yamamoto JK; Koyama H
    Vet Microbiol; 1997 Nov; 58(2-4):155-65. PubMed ID: 9453127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-emission fluorescence resonance energy transfer (FRET) real-time PCR differentiates feline immunodeficiency virus subtypes and discriminates infected from vaccinated cats.
    Wang C; Johnson CM; Ahluwalia SK; Chowdhury E; Li Y; Gao D; Poudel A; Rahman KS; Kaltenboeck B
    J Clin Microbiol; 2010 May; 48(5):1667-72. PubMed ID: 20335417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.